IL197926A0 - A stable composition comprising a bone anabolic protein, namely a pthrp analogue, and uses thereof - Google Patents

A stable composition comprising a bone anabolic protein, namely a pthrp analogue, and uses thereof

Info

Publication number: IL197926A0
Authority: IL; Israel
Prior art keywords: namely; stable composition; bone anabolic; pthrp analogue; anabolic protein
Prior art date: 2006-10-03

Application number

IL197926A

Other versions

IL197926A (en

Original Assignee

Ipsen Pharma Sas

Radius Health Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2006-10-03

Filing date

2009-04-05

Publication date

2011-08-01

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=39430237&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=IL197926(A0) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2007-10-03 Application filed by Ipsen Pharma Sas, Radius Health Inc filed Critical Ipsen Pharma Sas

2011-08-01 Publication of IL197926A0 publication Critical patent/IL197926A0/en

2014-08-31 Publication of IL197926A publication Critical patent/IL197926A/en

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/29—Parathyroid hormone, i.e. parathormone; Parathyroid hormone-related peptides
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/02—Inorganic compounds
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Epidemiology (AREA)
Engineering & Computer Science (AREA)
Physical Education & Sports Medicine (AREA)
Bioinformatics & Cheminformatics (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Endocrinology (AREA)
Organic Chemistry (AREA)
Orthopedic Medicine & Surgery (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Rheumatology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Gastroenterology & Hepatology (AREA)
Immunology (AREA)
Zoology (AREA)
Dermatology (AREA)
Oil, Petroleum & Natural Gas (AREA)
Inorganic Chemistry (AREA)
Oncology (AREA)
Communicable Diseases (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Medicinal Preparation (AREA)
Peptides Or Proteins (AREA)
Materials For Medical Uses (AREA)
Compositions Of Macromolecular Compounds (AREA)

IL197926A 2006-10-03 2007-10-03 Stable composition comprising a bone anabolic protein, namely a pthrp analogue, and uses thereof IL197926A (en)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US84896006P	2006-10-03	2006-10-03
PCT/US2007/021216 WO2008063279A2 (en)	2006-10-03	2007-10-03	A stable composition comprising a bone anabolic protein, namely a pthrp analogue, and uses thereof

Publications (2)

Publication Number	Publication Date
IL197926A0 true IL197926A0 (en)	2011-08-01
IL197926A IL197926A (en)	2014-08-31

Family

ID=39430237

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
IL197926A IL197926A (en)	2006-10-03	2007-10-03	Stable composition comprising a bone anabolic protein, namely a pthrp analogue, and uses thereof

Country Status (28)

Country	Link
US (1)	US8148333B2 (en)
EP (2)	EP2073789B8 (en)
JP (1)	JP5375611B2 (en)
KR (4)	KR20150020289A (en)
CN (2)	CN101578093B (en)
AU (1)	AU2007322334B2 (en)
BR (2)	BRPI0719821B8 (en)
CA (1)	CA2664734C (en)
CY (1)	CY1119198T1 (en)
DK (2)	DK2957278T3 (en)
ES (2)	ES2739459T3 (en)
FR (1)	FR23C1024I2 (en)
HR (1)	HRP20171217T1 (en)
IL (1)	IL197926A (en)
LT (1)	LT2957278T (en)
LU (1)	LUC00309I2 (en)
MX (1)	MX2009003569A (en)
NL (1)	NL301235I2 (en)
NO (1)	NO344885B1 (en)
NZ (1)	NZ576682A (en)
PL (1)	PL2957278T3 (en)
PT (2)	PT2957278T (en)
RS (1)	RS56164B1 (en)
RU (1)	RU2506070C2 (en)
SG (1)	SG175580A1 (en)
SI (1)	SI2957278T1 (en)
UA (1)	UA98776C2 (en)
WO (1)	WO2008063279A2 (en)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
LT2957278T (en)	2006-10-03	2017-09-11	Radius Health, Inc.	A stable composition comprising pthrp and uses thereof
USRE49444E1 (en)	2006-10-03	2023-03-07	Radius Health, Inc.	Method of treating osteoporosis comprising administration of PTHrP analog
US7803770B2 (en) *	2006-10-03	2010-09-28	Radius Health, Inc.	Method of treating osteoporosis comprising administration of PTHrP analog
EP3106159A1 (en)	2010-05-12	2016-12-21	Radius Health, Inc.	Therapeutic regimens
JP5965909B2 (en)	2010-09-28	2016-08-10	ラジウスヘルス，インコーポレイテッド	Selective androgen receptor modulator
EP2472328B1 (en)	2010-12-31	2013-06-19	Rohm and Haas Electronic Materials LLC	Coating compositions for use with an overcoated photoresist
EP2472329B1 (en)	2010-12-31	2013-06-05	Rohm and Haas Electronic Materials LLC	Coating compositions for use with an overcoated photoresist
EP2699252B1 (en)	2011-04-22	2017-10-25	Radius Health, Inc.	Method of drug delivery for pth, pthrp and related peptides
KR20150116467A (en) *	2011-06-07	2015-10-15	아사히 가세이 파마 가부시키가이샤	Freeze-dried preparation containing high-purity pth and method for producing same
CA2857501C (en)	2011-11-30	2020-06-23	3M Innovative Properties Company	Microneedle device having a peptide therapeutic agent and an amino acid, methods of making and using the same
CA2943611A1 (en)	2014-03-28	2015-10-01	Duke University	Method of treating cancer using selective estrogen receptor modulators
WO2016141250A1 (en) *	2015-03-03	2016-09-09	Radius Health, Inc.	USES OF PTHrP ANALOGUE IN REDUCING FRACTURE RISK
CA2984357A1 (en)	2015-04-29	2016-11-03	Radius Pharmaceuticals, Inc.	Methods for treating cancer
US20180161401A1 (en) *	2015-07-06	2018-06-14	Zheng Xin Dong	Novel Formulations of PTHrP Analogue
JP6525376B2 (en)	2015-08-31	2019-06-05	ロームアンドハースエレクトロニックマテリアルズエルエルシーＲｏｈｍａｎｄＨａａｓＥｌｅｃｔｒｏｎｉｃＭａｔｅｒｉａｌｓＬＬＣ	Coating composition for use with an overcoated photoresist
HUE055658T2 (en) *	2015-10-09	2021-12-28	Radius Health Inc	Formulations containing PTHRP analogs, transdermal patches containing them and their use
EP3481414B1 (en)	2016-04-18	2021-11-03	Radius Health, Inc.	Formulations of abaloparatide, transdermal patches thereof, and uses thereof
CA3027563C (en)	2016-06-22	2024-07-02	Ellipses Pharma Ltd	Ar+ breast cancer treatment methods
EP3548012A4 (en) *	2016-11-30	2020-07-22	Purdue Research Foundation	Fracture-directed bone regeneration by stimulating the parathyroid hormone receptor
JP7481115B2 (en)	2017-01-05	2024-05-10	ラジウスファーマシューティカルズ，インコーポレイテッド	Polymorphic forms of RAD1901-2HCL
US10996208B2 (en)	2017-04-28	2021-05-04	Radius Health, Inc.	Abaloparatide formulations and methods of testing, storing, modifying, and using same
WO2019175173A1 (en) *	2018-03-12	2019-09-19	Fresenius Kabi Ipsum S.R.L.	Process for the manufacture of pthrp analogue
WO2019232283A1 (en)	2018-05-30	2019-12-05	Purdue Research Foundation	Targeting anabolic drugs for accelerated fracture repair
IL279853B2 (en)	2018-07-04	2025-01-01	Radius Pharmaceuticals Inc	Polymorphic forms of rad 1901-2hcl
CN119390714A (en)	2019-02-12	2025-02-07	雷迪厄斯制药公司	Methods and compounds
EP4110371A1 (en)	2020-01-24	2023-01-04	Radius Health, Inc.	Methods of stimulating bone growth with abalopartide and denosumab
WO2023281447A1 (en)	2021-07-07	2023-01-12	Radius Health, Inc.	Methods of treating a cardiovascular ischemic event

Family Cites Families (26)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5589452A (en) *	1992-07-14	1996-12-31	Syntex (U.S.A.) Inc.	Analogs of parathyroid hormone and parathyroid hormone related peptide: synthesis and use for the treatment of osteoporosis
US5977070A (en) *	1992-07-14	1999-11-02	Piazza; Christin Teresa	Pharmaceutical compositions for the nasal delivery of compounds useful for the treatment of osteoporosis
US5821225A (en)	1992-07-14	1998-10-13	Syntex (U.S.A.) Inc.	Method for the treatment of corticosteroid induced osteopenia comprising administration of modified PTH or PTHrp
ES2179831T3 (en)	1992-09-29	2003-02-01	Inhale Therapeutic Syst	RELEASE IN THE LUNGS OF ACTIVE FRAGMENTS OF PARTIROIDIAN HORMONE.
WO1995002610A1 (en)	1993-07-13	1995-01-26	Syntex (U.S.A.) Inc.	Analogs of parathyroid hormone and parathyroid hormone related peptide: synthesis and use for the treatment of osteoporosis
US7410948B2 (en) *	1995-07-13	2008-08-12	Societe De Conseils De Recherches Et D'applications Scientifiques, Sas	Analogs of parathyroid hormone
US6544949B1 (en) *	1995-07-13	2003-04-08	Societe De Conseils De Recherches Et D'applications Scientifiques, S.A.S.	Analogs of parathyroid hormone
US5955574A (en) *	1995-07-13	1999-09-21	Societe De Conseils De Recherches Et D'applications Scientifiques, S.A.	Analogs of parathyroid hormone
US5969095A (en) *	1995-07-13	1999-10-19	Biomeasure, Inc.	Analogs of parathyroid hormone
US5723577A (en) *	1995-07-13	1998-03-03	Biomeasure Inc.	Analogs of parathyroid hormone
CN1204262A (en) *	1995-10-17	1999-01-06	曼海姆泊灵格股份公司	Stable pharmaceutical forms of administration containing parathormone
TW505654B (en) *	1996-07-30	2002-10-11	Hoffmann La Roche	Synthesis of analogs of PTH and PTHrP
US6136784A (en) *	1997-01-08	2000-10-24	Amylin Pharmaceuticals, Inc.	Amylin agonist pharmaceutical compositions containing insulin
CZ298701B6 (en)	1997-09-09	2007-12-27	F. Hoffman-La Roche Ag	Medicament for healing bones and repair of fractures
ZA9811127B (en)	1997-12-09	2000-07-11	Lilly Co Eli	Stabilized teriparatide solutions.
US6770623B1 (en)	1997-12-09	2004-08-03	Eli Lilly And Company	Stabilized teriparatide solutions
SE9801495D0 (en)	1998-04-28	1998-04-28	Astra Ab	Protein formulation
US20050124537A1 (en) *	2000-04-27	2005-06-09	Amgen Inc.	Modulators of receptors for parathyroid hormone and parathyroid hormone-related protein
US6756480B2 (en) *	2000-04-27	2004-06-29	Amgen Inc.	Modulators of receptors for parathyroid hormone and parathyroid hormone-related protein
US7371721B2 (en) *	2000-09-18	2008-05-13	Sanos Bioscience A/S	Use of GLP-2 and related compounds for the treatment, prevention, diagnosis, and prognosis of bone-related disorders and calcium homeostasis related syndromes
US7799757B2 (en)	2002-06-13	2010-09-21	Michael Chorev	Analogs of parathyroid hormone and PTH-related protein as bone anabolic agents
EP1567178A4 (en)	2002-11-01	2009-07-15	Amgen Inc	Modulators of receptors for parathyrois hormone and parathyroid hormone-related protein
TWI359026B (en)	2004-02-12	2012-03-01	Sankyo Co	Pharmaceutical composition for the osteoclast rela
CN101151048A (en) *	2004-05-10	2008-03-26	纳斯泰克制药公司	Compositions and methods for enhancing mucosal delivery of parathyroid hormone
US7803770B2 (en)	2006-10-03	2010-09-28	Radius Health, Inc.	Method of treating osteoporosis comprising administration of PTHrP analog
LT2957278T (en)	2006-10-03	2017-09-11	Radius Health, Inc.	A stable composition comprising pthrp and uses thereof

2007
- 2007-10-03 LT LTEP15176548.4T patent/LT2957278T/en unknown
- 2007-10-03 BR BRPI0719821A patent/BRPI0719821B8/en active IP Right Grant
- 2007-10-03 RS RS20170803A patent/RS56164B1/en unknown
- 2007-10-03 WO PCT/US2007/021216 patent/WO2008063279A2/en not_active Ceased
- 2007-10-03 RU RU2009116531/15A patent/RU2506070C2/en not_active IP Right Cessation
- 2007-10-03 ES ES07870768T patent/ES2739459T3/en active Active
- 2007-10-03 PT PT151765484T patent/PT2957278T/en unknown
- 2007-10-03 PL PL15176548T patent/PL2957278T3/en unknown
- 2007-10-03 CN CN2007800370219A patent/CN101578093B/en active Active
- 2007-10-03 DK DK15176548.4T patent/DK2957278T3/en active
- 2007-10-03 SG SG2011071784A patent/SG175580A1/en unknown
- 2007-10-03 ES ES15176548.4T patent/ES2637283T3/en active Active
- 2007-10-03 DK DK07870768.4T patent/DK2073789T3/en active
- 2007-10-03 KR KR20147033817A patent/KR20150020289A/en not_active Ceased
- 2007-10-03 EP EP07870768.4A patent/EP2073789B8/en active Active
- 2007-10-03 KR KR1020097008736A patent/KR101512377B1/en active Active
- 2007-10-03 EP EP15176548.4A patent/EP2957278B1/en not_active Revoked
- 2007-10-03 KR KR1020187030530A patent/KR20180117738A/en not_active Ceased
- 2007-10-03 CN CN201110220104.XA patent/CN102274492B/en active Active
- 2007-10-03 CA CA2664734A patent/CA2664734C/en active Active
- 2007-10-03 US US12/311,418 patent/US8148333B2/en active Active
- 2007-10-03 SI SI200731956T patent/SI2957278T1/en unknown
- 2007-10-03 UA UAA200904264A patent/UA98776C2/en unknown
- 2007-10-03 MX MX2009003569A patent/MX2009003569A/en active IP Right Grant
- 2007-10-03 KR KR1020177015557A patent/KR20170067906A/en not_active Ceased
- 2007-10-03 BR BRPI0722428-1A patent/BRPI0722428A2/en not_active Application Discontinuation
- 2007-10-03 IL IL197926A patent/IL197926A/en active IP Right Grant
- 2007-10-03 NZ NZ576682A patent/NZ576682A/en unknown
- 2007-10-03 JP JP2009531434A patent/JP5375611B2/en active Active
- 2007-10-03 PT PT07870768T patent/PT2073789T/en unknown
- 2007-10-03 AU AU2007322334A patent/AU2007322334B2/en active Active
2009
- 2009-04-20 NO NO20091545A patent/NO344885B1/en unknown
2017
- 2017-08-08 HR HRP20171217TT patent/HRP20171217T1/en unknown
- 2017-08-10 CY CY20171100860T patent/CY1119198T1/en unknown
2023
- 2023-06-05 LU LU00309C patent/LUC00309I2/en unknown
- 2023-06-05 FR FR23C1024C patent/FR23C1024I2/en active Active
- 2023-06-09 NL NL301235C patent/NL301235I2/en unknown

Also Published As

Publication number	Publication date
LUC00309I2 (en)	2025-09-22
JP5375611B2 (en)	2013-12-25
UA98776C2 (en)	2012-06-25
CA2664734A1 (en)	2008-05-29
FR23C1024I1 (en)	2023-07-21
PL2957278T3 (en)	2017-10-31
JP2010505835A (en)	2010-02-25
SG175580A1 (en)	2011-11-28
EP2957278B1 (en)	2017-05-17
KR20090083350A (en)	2009-08-03
WO2008063279A9 (en)	2008-07-10
PT2957278T (en)	2017-08-23
CN102274492B (en)	2014-11-26
RU2506070C2 (en)	2014-02-10
EP2957278A1 (en)	2015-12-23
HK1214181A1 (en)	2016-07-22
US8148333B2 (en)	2012-04-03
BRPI0719821A2 (en)	2013-05-07
NO344885B1 (en)	2020-06-15
BRPI0719821B1 (en)	2020-04-14
EP2073789A2 (en)	2009-07-01
CN101578093B (en)	2011-09-14
BRPI0722428A2 (en)	2013-11-26
DK2957278T3 (en)	2017-07-31
MX2009003569A (en)	2009-08-25
EP2073789B8 (en)	2023-02-08
NZ576682A (en)	2012-08-31
PT2073789T (en)	2019-07-31
BRPI0719821B8 (en)	2021-05-25
RS56164B1 (en)	2017-11-30
EP2073789B1 (en)	2019-05-22
KR20150020289A (en)	2015-02-25
HRP20171217T1 (en)	2017-10-20
SI2957278T1 (en)	2017-09-29
IL197926A (en)	2014-08-31
US20100029556A1 (en)	2010-02-04
WO2008063279A3 (en)	2009-06-25
RU2009116531A (en)	2010-11-10
AU2007322334B2 (en)	2011-12-22
AU2007322334A1 (en)	2008-05-29
CN101578093A (en)	2009-11-11
KR20170067906A (en)	2017-06-16
FR23C1024I2 (en)	2024-06-14
KR101512377B1 (en)	2015-04-28
WO2008063279A2 (en)	2008-05-29
NO20091545L (en)	2009-05-27
DK2073789T3 (en)	2019-08-05
CN102274492A (en)	2011-12-14
LT2957278T (en)	2017-09-11
KR20180117738A (en)	2018-10-29
NL301235I2 (en)	2023-08-31
CA2664734C (en)	2023-08-01
ES2637283T3 (en)	2017-10-11
CY1119198T1 (en)	2018-02-14
ES2739459T3 (en)	2020-01-31

Publication	Publication Date	Title
IL197926A0 (en)	2011-08-01	A stable composition comprising a bone anabolic protein, namely a pthrp analogue, and uses thereof
EP1988922A4 (en)	2010-06-02	Protein formulations
EP2039366A4 (en)	2010-01-06	Composition containing peptide as the active ingredient
IL223477A (en)	2017-10-31	Pharmaceutical composition comprising modified uricase
IL192104A0 (en)	2008-12-29	Stable protein formulations
ZA200901132B (en)	2010-10-27	Human GLP-1 mimetibodies, compositions, methods and uses
IL195813A0 (en)	2009-09-22	Substituted aminopyrazolopyridines and salts thereof, their preparations and pharmaceutical compositions comprising them
IL193700A0 (en)	2011-08-01	Medicaments and proteins
IL187534A0 (en)	2008-03-20	Thiazole derivatives, use thereof and pharmaceutical compositions containing them
EP1976864A4 (en)	2010-09-01	Novel peptide and use thereof
ZA200900673B (en)	2010-04-28	18-methyl-19-nor-androst-4-en-17, 17-spiroether (18-methyl-19-nor-20-spirox-4-en-3-one) and pharmaceutical preparations containing the same
EP2261221A4 (en)	2011-08-10	Epothilone analogues, their pharmaceutical compositions, their use and their preparations
IL186258A0 (en)	2008-01-20	Chimeric proteins, their preparation and pharmaceutical compositions containing them
ZA200900237B (en)	2010-03-31	Substituted aminopyrazolopyridines and salts thereof, their preparations and pharmaceutical compositions comprising them
EP2025667A4 (en)	2012-08-29	9,10-secopregnane derivative and pharmaceutical
IL192824A (en)	2015-04-30	Peptidic compounds, pharmaceutical compositions comprising them and uses thereof
IL184631A0 (en)	2009-09-22	PHARMACEUTICAL COMPOSITIONS CONTAINING A Wht3a PROTEIN
ZA200704926B (en)	2008-12-31	Modified human growth hormone
GB0604187D0 (en)	2006-04-12	Peptide and uses thereof
ZA200808768B (en)	2009-07-29	Pharmaceutical composition containing the NMB0606 protein
ZA201005398B (en)	2012-12-27	15,16-methylene-17-(1'-propenyl)-17,3'-oxidoestra-4-en-3-one derivative,use thereof,and medicament containing said derivative
ZA200808769B (en)	2009-09-11	Pharmaceutical compostion containing the NMB0938 protein
IL189827A0 (en)	2008-11-03	Pharmaceutical dosage forms and compositions comprising lecoztan
IL190926A0 (en)	2009-09-22	A pharmaceutical composition containing a tissue protein
ZA200808328B (en)	2009-12-30	Peptide compound with biological activity,its preparation and its application

Legal Events

Date	Code	Title
2014-12-31	FF	Patent granted
2014-12-31	KB	Patent renewed
2017-09-28	KB	Patent renewed
2021-10-31	KB	Patent renewed